RA
Rakesh Arunkumar Doshi
About Rakesh Arunkumar Doshi
Data last updated:
Rakesh Arunkumar Doshi is a Director at Kopran Research Laboratories Limited (since 2017) and Director at Duram Pharmachem Private Limited (since 1994). The companies operate in Pharma, Real Estate and Construction and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹367 Cr; the largest is Kopran Research Laboratories Limited at ₹366 Cr (FY 2025). Earlier, Rakesh Arunkumar Doshi was an Additional Director at Ariane Orgachem Private Limited (2006–2007) and Director at Finekem Laboratories Private Limited (2005–2009) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Nov 2017 | 1986 | ₹366 Cr (FY 2025) | Active | |
| Director | 28 Oct 1994 | 1994 | ₹1.44 Cr (FY 2021) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 05 Jun 2006 | 1987 | ₹24.19 Cr (FY 2025) | Active | |
| Director | 21 Jun 2005 | 2003 | ₹28.16 Cr (FY 2017) | Amalgamated | |
| Nominee Director | 03 Jan 2015 | 1996 | ₹14.26 Cr (FY 2015) | Under Liquidation | |
| Whole-Time Director | 17 Jan 2008 | 2007 | ₹53.35 Cr (FY 2017) | Amalgamated | |
| Additional Director | 15 Dec 2006 | 2001 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rakesh Arunkumar Doshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandra Mohan Singhi | 01793293 | Kopran Research Laboratories Limited | Whole-Time Director |
| Deepika Nirmalsingh Mertia | Kopran Research Laboratories Limited | Company Secretary | |
| Lekha Deepakkumar Jogi | Kopran Research Laboratories Limited | Cfo | |
| Mamta Ashok Biyani | 01850136 | Kopran Research Laboratories Limited | Director |
| Sunita Banerji | 02476075 | Kopran Research Laboratories Limited | Director |
| Vandana Surendra Somani | 01218254 | Kopran Research Laboratories Limited | Director |
| Usha Rakesh Doshi | 01353747 | Duram Pharmachem Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Arunkumar Doshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Arunkumar Doshi
Rakesh Arunkumar Doshi currently holds 2 directorships: Kopran Research Laboratories Limited (Director, since 14 Nov 2017, revenue ₹366 Cr (FY 2025)); Duram Pharmachem Private Limited (Director, since 28 Oct 1994, revenue ₹1.44 Cr (FY 2021)).
Rakesh Arunkumar Doshi was first appointed on 28 Oct 1994 as Director at Duram Pharmachem Private Limited. The most recent appointment on record is 14 Nov 2017 at Kopran Research Laboratories Limited.
The 2 current companies of Rakesh Arunkumar Doshi that report revenue have a combined latest revenue of ₹367 Cr: Kopran Research Laboratories Limited ₹366 Cr (FY 2025); Duram Pharmachem Private Limited ₹1.44 Cr (FY 2021).
Rakesh Arunkumar Doshi held 5 earlier board appointments: Ariane Orgachem Private Limited (Additional Director, 05 Jun 2006 to 30 Jun 2007); Finekem Laboratories Private Limited (Director, 21 Jun 2005 to 22 Apr 2009); Shri Aster Silicates Limited (Nominee Director, 03 Jan 2015 to 30 Jan 2016); Amri India Private Limited (Whole-Time Director, 17 Jan 2008 to 29 Apr 2009); Ferico Laboratories Limited (Additional Director, 15 Dec 2006 to 30 Jun 2007).
The current boards of Rakesh Arunkumar Doshi's companies include Chandra Mohan Singhi (Kopran Research Laboratories Limited), Deepika Nirmalsingh Mertia (Kopran Research Laboratories Limited), Lekha Deepakkumar Jogi (Kopran Research Laboratories Limited), Mamta Ashok Biyani (Kopran Research Laboratories Limited), Sunita Banerji (Kopran Research Laboratories Limited), Vandana Surendra Somani (Kopran Research Laboratories Limited), among others.